Cargando…

Inflammatory Mechanisms of Neurodegeneration in Toxin-Based Models of Parkinson's Disease

Parkinson's disease (PD) has been associated with exposure to a variety of environmental agents, including pesticides, heavy metals, and organic pollutants; and inflammatory processes appear to constitute a common mechanistic link among these insults. Indeed, toxin exposure has been repeatedly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Litteljohn, Darcy, Mangano, Emily, Clarke, Melanie, Bobyn, Jessica, Moloney, Kerry, Hayley, Shawn
Formato:	Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018622/ https://www.ncbi.nlm.nih.gov/pubmed/21234362 http://dx.doi.org/10.4061/2011/713517

Ejemplares similares

Viral-toxin interactions and Parkinson’s disease: poly(I:C) priming enhanced the neurodegenerative effects of paraquat
por: Bobyn, Jessica, et al.
Publicado: (2012)

Use of induced pluripotent stem cell derived neurons engineered to express BDNF for modulation of stressor related pathology
por: Liu, Gele, et al.
Publicado: (2014)

Neuroplasticity and the next wave of antidepressant strategies
por: Hayley, Shawn, et al.
Publicado: (2013)

Stressor-Like Effects of c-Jun N-Terminal Kinase (JNK) Inhibition
por: Clarke, Melanie, et al.
Publicado: (2012)

IFN-γ differentially modulates memory-related processes under basal and chronic stressor conditions
por: Litteljohn, Darcy, et al.
Publicado: (2014)

Antidepressant-Like Effects of Erythropoietin: A Focus on Behavioural and Hippocampal Processes
por: Osborn, Meagan, et al.
Publicado: (2013)

The interactive effects of ketamine and magnesium upon depressive-like pathology
por: Razmjou, Sara, et al.
Publicado: (2016)

Paraquat and psychological stressor interactions as pertains to Parkinsonian co-morbidity
por: Rudyk, Chris, et al.
Publicado: (2015)

Age and Chronicity of Administration Dramatically Influenced the Impact of Low Dose Paraquat Exposure on Behavior and Hypothalamic-Pituitary-Adrenal Activity
por: Rudyk, Chris A., et al.
Publicado: (2017)

Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson’s Disease
por: Surguchov, Andrei
Publicado: (2021)

BMAA, Methylmercury, and Mechanisms of Neurodegeneration in Dolphins: A Natural Model of Toxin Exposure
por: Davis, David A., et al.
Publicado: (2021)

Shared Mechanisms of Neurodegeneration in Alzheimer's Disease and Parkinson's Disease
por: Xie, Anmu, et al.
Publicado: (2014)

Mechanisms of Neurodegeneration in Various Forms of Parkinsonism—Similarities and Differences
por: Koziorowski, Dariusz, et al.
Publicado: (2021)

Neurodegeneration and neuroprotection in Parkinson's disease /
Publicado: (1996)

Combined Ubisol-Q(10) and Ashwagandha Root Extract Target Multiple Biochemical Mechanisms and Reduces Neurodegeneration in a Paraquat-Induced Rat Model of Parkinson’s Disease
por: Vegh, Caleb, et al.
Publicado: (2021)

Mutant LRRK2 in lymphocytes regulates neurodegeneration via IL-6 in an inflammatory model of Parkinson’s disease
por: Kozina, Elena, et al.
Publicado: (2022)

Single-neuron neurodegeneration as a degenerative model for Parkinson’s disease
por: Huenchuguala, Sandro, et al.
Publicado: (2023)

Cyclooxygenase and Neuroinflammation in Parkinson’s Disease Neurodegeneration
por: Bartels, Anna L, et al.
Publicado: (2010)

Parkinson’s disease managing reversible neurodegeneration
por: Hinz, Marty, et al.
Publicado: (2016)

Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease
por: Gelders, Géraldine, et al.
Publicado: (2018)

Modeling of the Progressive Degradation of the Nigrostriatal Dopaminergic System in Mice to Study the Mechanisms of Neurodegeneration and Neuroplasticity in Parkinson’s Disease
por: Kolacheva, Anna, et al.
Publicado: (2022)

Oxidative Stress Mechanisms Underlying Parkinson’s Disease-Associated Neurodegeneration in C. elegans
por: Chakraborty, Sudipta, et al.
Publicado: (2013)

Parkinson's disease: Microglial/macrophage-induced immunoexcitotoxicity as a central mechanism of neurodegeneration
por: Blaylock, Russell L.
Publicado: (2017)

Editorial: Mechanisms of neuroinflammation and inflammatory neurodegeneration in acute brain injury
por: Liesz, Arthur, et al.
Publicado: (2015)

Dopamine Induced Neurodegeneration in a PINK1 Model of Parkinson's Disease
por: Gandhi, Sonia, et al.
Publicado: (2012)

The role of astrocytes in prion-like mechanisms of neurodegeneration
por: Smethurst, Phillip, et al.
Publicado: (2022)

Parkinson's Disease and Neurodegeneration: GABA-Collapse Hypothesis
por: Błaszczyk, Janusz W.
Publicado: (2016)

Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease
por: Zeng, Xian-Si, et al.
Publicado: (2018)

The Role of LRRK2 in Neurodegeneration of Parkinson Disease
por: Rui, Qin, et al.
Publicado: (2018)

Parkinson’s disease managing reversible neurodegeneration [Corrigendum]
Publicado: (2016)

Neurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease
por: Marogianni, Chrysoula, et al.
Publicado: (2020)

Microbial BMAA and the Pathway for Parkinson’s Disease Neurodegeneration
por: Nunes-Costa, Daniela, et al.
Publicado: (2020)

Parkinson’s Disease Managing Reversible Neurodegeneration [Retraction]
Publicado: (2020)

Association of p53 with Neurodegeneration in Parkinson's Disease
por: Luo, Qiang, et al.
Publicado: (2022)

Toxin-Induced and Genetic Animal Models of Parkinson's Disease
por: Hisahara, Shin, et al.
Publicado: (2010)

Sulfide:quinone oxidoreductase ameliorates neurodegeneration in a murine model of Parkinson's disease
por: Nagashima, Fumiaki, et al.
Publicado: (2022)

Aging and Neurodegeneration: A Tangle of Models and Mechanisms
por: Chakrabarti, Sasanka, et al.
Publicado: (2016)

Brain Mitochondrial Dysfunction in Aging, Neurodegeneration, and Parkinson's Disease
por: Navarro, Ana, et al.
Publicado: (2010)

Cerebral and Extracranial Neurodegeneration are Strongly Coupled in Parkinson’s Disease
por: Spiegel, Jörg, et al.
Publicado: (2007)

Editorial: Protein Degradation Pathways in Parkinson's Disease and Neurodegeneration
por: Volta, Mattia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9e148e1tran61tfrgvuqmq1888